ARCHIVES

DeVita Resigns As No. 2 At Sloan-Kettering To “Pursue Clinical Research,” Hospital Says

This article is from The Cancer Letter archive.

Vol. 17 No. 22 | May 31, 1991

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Discussing Pharmacological Prevention

July 26, 2013

In Brief: Tipping Resigns Forom ACS; Vaughan Joins UAB BMT Program; PCI Recruits Ball, Finn, Mirro

September 20, 1991

ASCO Entering Prime Of Life

May 31, 1991

In Brief: Some Cancer Centers Funded At “Recommended” Levels For Fiscal 1981, But There Was A Catch

October 30, 1981

NCI Reportedly Gets $691 Million From House, Senate Conferees

October 4, 1974

Tamoxifen Trial may EB Funded In Part With CCOP Money

March 22, 1991